Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema

BACKGROUND: To assess the cost-effectiveness of the delayed-release device of dexamethasone compared with aflibercept in the treatment of patients with naïve diabetic macular edema (DME) from a societal perspective in the healthcare sector Zaragoza III in Spain. METHODS: A Markov model with five sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Montes Rodríguez, Paula, Mateo Gabás, Javier, Esteban Floría, Olivia, Honrubia Grijalbo, Ana, Ascaso Puyuelo, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713987/
https://www.ncbi.nlm.nih.gov/pubmed/36457024
http://dx.doi.org/10.1186/s12962-022-00401-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713987/
https://www.ncbi.nlm.nih.gov/pubmed/36457024
http://dx.doi.org/10.1186/s12962-022-00401-z

Ejemplares similares